# A Phase 1 Study of SB1518 for the Treatment of Advanced Lymphoid Malignancies

> **NCT00741871** · PHASE1 · COMPLETED · sponsor: **S*BIO** · enrollment: 35 (actual)

## Conditions studied

- Lymphoma, Malignant
- Hodgkin's Lymphoma
- B Cell Lymphoma

## Interventions

- **DRUG:** SB1518

## Key facts

- **NCT ID:** NCT00741871
- **Lead sponsor:** S*BIO
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07
- **Primary completion:** 2011-10
- **Final completion:** 2011-10
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2012-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00741871

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00741871, "A Phase 1 Study of SB1518 for the Treatment of Advanced Lymphoid Malignancies". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00741871. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*